Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Active Recombinant Human VWF protein, Met/His-tagged

Cat.No. : VWF-2712H
Product Overview : Recombinant Human VWF(Asp1498-Val1665) fused with Met/His tag at N-terminal was expressed in E. coli.
  • Specification
  • Gene Information
  • Related Products
Source : E. coli
Species : Human
Tag : Met/His
Predicted N Terminal : Met
Form : Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Bio-activity : Measured by its ability to be used as a protein substrate for ADAMTS13. >50% of rhvWF-A2 is cleaved as measured under the described conditions.
Molecular Mass : Predicted Molecular Mass: 20 kDa;SDS-PAGE: 18 kDa, reducing conditions.
Endotoxin : <1.0 EU per 1 μg of the protein by the LAL method.
Purity : >90%, by SDS-PAGE under reducing conditions and visualized by silver stain
Storage : Avoid repeated freeze-thaw cycles.6 months from date of receipt, -20 to -70 centigrade as supplied.3 months, -20 to -70 centigrade under sterile conditions after opening.
Gene Name : VWF von Willebrand factor [ Homo sapiens ]
Official Symbol : VWF
Synonyms : VWF; von Willebrand factor; F8VWF; coagulation factor VIII VWF; VWD;
Gene ID : 7450
mRNA Refseq : NM_000552
Protein Refseq : NP_000543
MIM : 613160
UniProt ID : P04275
Chromosome Location : 12p13.3
Pathway : Blood Clotting Cascade, organism-specific biosystem; Complement and Coagulation Cascades, organism-specific biosystem; Complement and coagulation cascades, organism-specific biosystem; Complement and coagulation cascades, conserved biosystem; ECM-receptor interaction, organism-specific biosystem; ECM-receptor interaction, conserved biosystem; Focal Adhesion, organism-specific biosystem;
Function : chaperone binding; collagen binding; glycoprotein binding; immunoglobulin binding; integrin binding; protease binding; protease binding; protein N-terminus binding; protein binding; protein homodimerization activity;

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (6)

Ask a question
How can treatment be used to change the level or function of the VWF protein? 09/15/2022

There is currently no treatment that directly targets the VWF protein. However, some medications can improve the patient's clotting status and reduce the risk of bleeding. For example, the use of recombinant human coagulation factor VIII. can replace the deficient factor VIII and improve coagulation function. In addition, the use of antifibrinolytic drugs can inhibit the degradation of fibrin and maintain the stability of the coagulation process.

What is the relationship between VWF protein and coagulation factor VIII? 04/28/2022

VWF protein is closely related to coagulation factor VIII. Coagulation factor VIII. is a serine protease that plays a key role in the coagulation process. VWF protein can act as a cofactor for coagulation factor VIII., accelerating the coagulation process. In addition, VWF protein can also inhibit the activity of plasminogen activators, thereby inhibiting the degradation of fibrin and maintaining the stability of the coagulation process.

How does VWF play a role in hemostasis? 10/24/2020

In the process of hemostasis, the role of VWF protein is mainly to promote platelet adhesion and aggregation. When platelets bind to VWF protein, morphological changes occur and the phospholipid surface is exposed, which interacts with other platelets or endothelial cells to form platelet thrombosis and play a hemostatic role.

Is VWF protein related to other coagulation factors? 04/21/2020

There is a complex interaction between VWF protein and other coagulation factors. For example, VWF proteins can bind to glycoprotein II.b/III.a receptors on the surface of platelets, promoting platelet adhesion and aggregation.

What is the association between genetic variation in VWF protein and disease? 03/29/2020

Genetic variations in the VWF protein can lead to coagulation disorders such as von Willebrand disease (VWD). Some variants can cause VWF protein deficiency or dysfunction, which can affect the ability of platelets to adhere and aggregate, increasing the risk of bleeding. Understanding these variants can help diagnose and classify different subtypes of VWD.

What is the function of VWF protein in blood? 02/10/2020

The main function of VWF protein in blood is to promote platelet adhesion and aggregation, thereby participating in the process of hemostasis and coagulation. In addition, VWF protein can also act as a regulator of endothelial cells and participate in the repair and remodeling of blood vessel walls.

Customer Reviews (3)

Write a review
Reviews
08/25/2022

    Strong activity, a small amount can play a role, save reagents.

    03/31/2021

      It has been used in experiments, and the results are accurate and reliable.

      02/10/2021

        No significant difference was found between different batches, and the repeatability between batches was good.

        Ask a Question for All VWF Products

        Required fields are marked with *

        My Review for All VWF Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends